Corcept Therapeutics Incorporated · NASDAQ:CORT
Wilson James N sold 10,000 Corcept Therapeutics Incorporated shares (Form 4)
Traded Oct 15, 2026 · Filed Oct 16, 2026
On Oct 15, 2026, Wilson James N (Director) sold 10,000 Corcept Therapeutics Incorporated shares at an average US$114.81 for US$1.15M under a trading plan, leaving 1,054,543 shares. Filed Oct 16, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$114.81 average (US$114.48 to US$116.30)
- Value
- US$1.15M
- Holding after
- 1,054,543 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Common Stock | Sale | 6,654 | US$114.48 | 1,057,889 | Indirect |
| Oct 15, 2026 | Common Stock | Sale | 3,046 | US$115.39 | 1,054,843 | Indirect |
| Oct 15, 2026 | Common Stock | Sale | 300 | US$116.30 | 1,054,543 | Indirect |
Source
Download original · View original at SEC
Related
- Corcept Therapeutics Incorporated
- Wilson James N
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Wilson James N · Sep 16, 2026
- Form 4 · Wilson James N · Aug 18, 2026
- Form 4 · Wilson James N · Jul 17, 2026
- Form 4 · Wilson James N · Jun 18, 2026
- Form 4 · Wilson James N · May 29, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026
- Form 4 · Robb Gary Charles · Sep 18, 2026